712582
O-[N-(3-马来酰亚胺丙酰)氨基乙基]-O′-[3-(N-琥珀酰亚氨氧基)-3-氧代丙基]三甘醇
≥90% (NMR)
别名:
N-[15-[(2,5-二氧代-1-吡咯烷基）氧基]-15-氧代-3,6,9,12-四氧杂十五-1-基]-2,5-二氢-2,5-二氧代-1H-吡咯-1-丙酰胺, 单分散 Mal-PEG4-NHS-酯
选择尺寸
关于此项目
InChI
1S/C22H31N3O11/c26-17(5-8-24-18(27)1-2-19(24)28)23-7-10-33-12-14-35-16-15-34-13-11-32-9-6-22(31)36-25-20(29)3-4-21(25)30/h1-2H,3-16H2,(H,23,26)
SMILES string
O=C(NCCOCCOCCOCCOCCC(ON1C(CCC1=O)=O)=O)CCN2C(C=CC2=O)=O
InChI key
XSRYGQJQNPJNKZ-UHFFFAOYSA-N
assay
≥90% (NMR)
form
liquid
reaction suitability
reagent type: cross-linking reagent
functional group
NHS ester, maleimide
storage temp.
−20°C
Quality Level
Packaging
存储类别
10 - Combustible liquids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
商品
Circulatory half-life is a key success factor for new drugs. In this respect, PEGylation or PEG-ing—the modification of potential candidates ranging from non-peptidic small molecules to peptides and proteins, antibody fragments, aptamers, and saccharides or oligonucleotides with polyethylene glycol chains—offers numerous advantages.
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持